Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Treasury Shares: 2019-2022

Historic Treasury Shares for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $679,000.

  • ADC Therapeutics' Treasury Shares fell 435.64% to -$541,000 in Q3 2023 from the same period last year, while for Sep 2023 it was -$541,000, marking a year-over-year decrease of 435.64%. This contributed to the annual value of $679,000 for FY2022, which is 430.47% up from last year.
  • ADC Therapeutics' Treasury Shares amounted to $679,000 in FY2022, which was up 430.47% from $128,000 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Treasury Shares registered a high of $679,000 during FY2022, and its lowest value of $100,000 during FY2019.
  • Its 1-year average for Treasury Shares is $8.4 million, with a median of $8.4 million in 2022.
  • Data for ADC Therapeutics' Treasury Shares shows a peak YoY surged of 430.47% (in 2022) over the last 5 years.
  • ADC Therapeutics' Treasury Shares (Yearly) stood at $100,000 in 2019, then reached $128,000 in 2021, then surged by 430.47% to $679,000 in 2022.